Trials / Completed
CompletedNCT01568190
An Open Trial to Assess the Tolerability of AVANZ Mite Mix Immunotherapy
An Open Trial to Asses the Tolerability of AVANZ Mite Mix Immunotherapy
- Status
- Completed
- Phase
- Phase 2 / Phase 3
- Study type
- Interventional
- Enrollment
- 102 (actual)
- Sponsor
- ALK-Abelló A/S · Industry
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of the trial is to assess the tolerability of the up-dosing phase of AVANZ Mite mix.
Detailed description
The frequency of patients with adverse reactions will be the primary endpoint.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | AVANZ MITE | Immunotherapy Dermatophagoides mix |
Timeline
- Start date
- 2011-12-01
- Primary completion
- 2012-07-01
- Completion
- 2012-07-01
- First posted
- 2012-04-02
- Last updated
- 2015-01-06
Locations
1 site across 1 country: Spain
Source: ClinicalTrials.gov record NCT01568190. Inclusion in this directory is not an endorsement.